200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 241799-10-0

241799-10-0

241799-10-0 | [1-(Quinolin-5-yl)-5-cyclopropyl-1H-pyrazole-4-carbonyl]guanidinedihydrochloride

CAS No: 241799-10-0 Catalog No: AG01ENPH MDL No:

Product Description

Catalog Number:
AG01ENPH
Chemical Name:
[1-(Quinolin-5-yl)-5-cyclopropyl-1H-pyrazole-4-carbonyl]guanidinedihydrochloride
CAS Number:
241799-10-0
IUPAC Name:
5-cyclopropyl-N-(diaminomethylidene)-1-quinolin-5-ylpyrazole-4-carboxamide;dihydrochloride
InChI:
InChI=1S/C17H16N6O.2ClH/c18-17(19)22-16(24)12-9-21-23(15(12)10-6-7-10)14-5-1-4-13-11(14)3-2-8-20-13;;/h1-5,8-10H,6-7H2,(H4,18,19,22,24);2*1H
InChI Key:
ARZNPJAGKWHEHT-UHFFFAOYSA-N

Properties

Complexity:
515  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
392.092g/mol
Formal Charge:
0
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
393.272g/mol
Monoisotopic Mass:
392.092g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
112A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
Chemical stability of amorphous materials: specific and general media effects in the role of water in the degradation of freeze-dried zoniporide. Journal of pharmaceutical sciences 20120901
Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide. Drug metabolism and disposition: the biological fate of chemicals 20120801
Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs. Drug metabolism and disposition: the biological fate of chemicals 20120301
Cross-reactivity of acid-sensing ion channel and Na⁺-H⁺ exchanger antagonists with nicotinic acetylcholine receptors. The Journal of physiology 20111101
Role of the spinal Na+/H+ exchanger in formalin-induced nociception. Neuroscience letters 20110821
Critical role of the STAT3 pathway in the cardioprotective efficacy of zoniporide in a model of myocardial preservation - the rat isolated working heart. British journal of pharmacology 20110201
Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences. Drug metabolism and disposition: the biological fate of chemicals 20100401
Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress? Journal of molecular and cellular cardiology 20090201
Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct. Brain research 20090112
Na+/H+ exchanger-1 inhibitors reduce neuronal excitability and alter na+ channel inactivation properties in rat primary sensory neurons. Toxicological sciences : an official journal of the Society of Toxicology 20080601
Neurotoxic effects of zoniporide: a selective inhibitor of the NA+/H+ exchanger isoform 1. Toxicologic pathology 20080601
Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery? Acta anaesthesiologica Belgica 20080101
Solute diffusion through stripped mouse duodenum. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20071201
Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes postresuscitation myocardial dysfunction through benefits on energy metabolism. Critical care medicine 20071001
The rise of [Na(+)] (i) during ischemia and reperfusion in the rat heart-underlying mechanisms. Pflugers Archiv : European journal of physiology 20070901
Initial rate analysis of zoniporide hydrolysis degradants using high-performance liquid chromatography coupled with mass spectrometric detection. Pharmaceutical development and technology 20070101
Efficacy of zoniporide, an Na/H exchange ion inhibitor, for reducing perioperative cardiovascular events in vascular surgery patients. Journal of cardiothoracic and vascular anesthesia 20051001
Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass. British journal of pharmacology 20040501
Basolateral Na+-H+ exchanger-1 in rat taste receptor cells is involved in neural adaptation to acidic stimuli. The Journal of physiology 20040401
Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1). Cardiovascular drug reviews 20030101
Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1. European journal of pharmacology 20020906
A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. The Journal of pharmacology and experimental therapeutics 20010401
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. Bioorganic & medicinal chemistry letters 20010326

Related Products

© 2019 Angene International Limited. All rights Reserved.